Optimum Investment Advisors Eli Lilly & CO Transaction History

Optimum Investment Advisors

$227 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$525.19 - $619.13 $525 - $619	-1 Reduced 0.22%	450 $262,000
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $434 - $599	1 Added 0.22%	451 $242,000
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $931 - $1,094	-3 Reduced 0.66%	450 $154,000
Q4 2022 Jan 05, 2023	SELL	$321.55 - $374.67 $144,697 - $168,601	-450 Reduced 49.83%	453 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $889 - $1,013	3 Added 0.33%	903 $292,000
Q1 2022 Apr 08, 2022	SELL	$234.69 - $291.66 $93,876 - $116,664	-400 Reduced 30.77%	900 $258,000
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $182,820 - $224,985	-825 Reduced 38.82%	1,300 $300,000
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $212,146 - $274,409	-1,175 Reduced 35.61%	2,125 $488,000
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $107,629 - $142,419	-825 Reduced 20.0%	3,300 $557,000
Q3 2020 Oct 06, 2020	SELL	$146.22 - $169.13 $120,631 - $139,532	-825 Reduced 16.67%	4,125 $611,000
Q2 2020 Jul 16, 2020	BUY	$136.42 - $164.18 $36,560 - $44,000	268 Added 5.72%	4,950 $813,000
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $152,145 - $188,313	-1,278 Reduced 21.44%	4,682 $649,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $10,692 - $13,243	-100 Reduced 1.65%	5,960 $783,000
Q3 2019 Oct 17, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 1.62%	6,060 $678,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $6,647 - $7,759	-60 Reduced 0.96%	6,160 $682,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $99,065 - $116,607	-890 Reduced 12.52%	6,220 $807,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $5,295 - $5,932	-50 Reduced 0.7%	7,110 $823,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $29,683 - $35,040	-400 Reduced 5.29%	7,160 $554,000
Q3 2017 Nov 21, 2017	SELL	$77.07 - $85.54 $12,793 - $14,199	-166 Reduced 2.15%	7,560 $647,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,726	7,726 $636,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.1 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$51.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.5 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.7 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Account